Core Viewpoint - The stock of Elon Technology (688329) has shown a significant increase of 4.47% on February 13, 2026, closing at 27.37 yuan, with notable trading activity and capital flow dynamics [1][2]. Capital Flow Summary - On February 13, 2026, the net inflow of main funds was 688.01 million yuan, accounting for 10.01% of the total transaction amount, while retail investors experienced a net outflow of 819.12 million yuan, representing 11.92% of the total [1][2]. - Over the past five days, the stock has seen fluctuating capital flows, with the highest net inflow of main funds recorded on February 9, 2026, at 62.21 million yuan, and the largest net outflow of retail funds on February 13, 2026, at 819.12 million yuan [2]. Financing and Securities Lending Data - On February 13, 2026, the financing balance was 49.08 million yuan, with a net financing purchase of 7.45 million yuan, while there were no securities lent or repaid [3]. - The financing balance has shown a steady increase over the past five days, with the highest balance recorded on February 13, 2026, at 49.08 million yuan [3]. Company Performance Metrics - Elon Technology's total market value is 2.113 billion yuan, significantly lower than the industry average of 13.873 billion yuan, ranking 564th in the industry [5]. - The company reported a net profit of -0.9589 million yuan, with a net profit margin of -0.92%, indicating challenges in profitability compared to the industry average of 4.36% [5]. - The gross profit margin stands at 45.79%, which is above the industry average of 31.6%, ranking 49th in the industry [5]. - For the first three quarters of 2025, the company achieved a main revenue of 280 million yuan, a year-on-year increase of 25.12%, while the net profit showed a significant improvement from the previous year [5].

证券代码：688329 证券简称：艾隆科技 公告编号：2026-009 苏州艾隆科技股份有限公司 关于变更签字注册会计师的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 苏州艾隆科技股份有限公司（以下简称"公司"）于 2025 年 10 月 24 日、 2025 年 11 月 14 日分别召开第五届董事会第十次会议、2025 年第二次临时股东 大会，审议通过了《关于续聘 2025 年度审计机构的议案》，同意继续聘请立信 会计师事务所（特殊普通合伙）（以下简称"立信"）为公司 2025 年度审计机 构，为公司提供 2025 年度财务报表审计和内部控制审计服务。具体内容详见公 司 于 2025 年 10 月 28 日 、 2025 年 11 月 15 日 在 上 海 证 券 交 易 所 网 站 （www.sse.com.cn）披露的《艾隆科技关于续聘 2025 年度审计机构的公告》（公 告编号：2025-050）、《艾隆科技 2025 年第二次临时股东大会决议公告》（公 告编号：2025-054）。 近日，公司收到立信发来 ...

苏州艾隆科技股份有限公司 2026 年第一次临时股东会会议资料 苏州艾隆科技股份有限公司 2026 第一次临时股东会会议资料 证券代码：688329 证券简称：艾隆科技 苏州艾隆科技股份有限公司 2026 年第一次临时股东会会议资料 2026 年 2 月 苏州艾隆科技股份有限公司 2026 年第一次临时股东会会议资料 苏州艾隆科技股份有限公司 2026 年第一次临时股东会会议资料目录 | 2026 年第一次临时股东会会议须知 1 | | --- | | 年第一次临时股东会会议议程 3 2026 | | 《关于公司及子公司向参股公司提供财务资助的议案》 5 | | 《关于控股孙公司终止前期购买资产事项并拟购买新资产暨关联交易的议案》 9 | | 《关于公司减少投资基金出资额暨关联交易的议案》 17 | 苏州艾隆科技股份有限公司 2026 年第一次临时股东会会议须知 为维护广大投资者的合法权益，保障股东在本次股东会期间依法行使权利， 根据《中华人民共和国公司法》、中国证监会《上市公司股东会规则》和公司《股 东会议事规则》等有关规定，特制定本会议须知： 一、苏州艾隆科技股份有限公司（以下简称"公司"）负责本次股东会 ...

Core Viewpoint - Suzhou Ailong Technology Co., Ltd. is responding to regulatory inquiries regarding its related party transactions, specifically the termination of a second transaction and the initiation of a third transaction for purchasing factory assets, emphasizing the strategic necessity and commercial rationale behind these decisions [1][2][3]. Group 1: Transaction Details - The company plans to terminate the second transaction to purchase Factory 1 for 13.5 million yuan due to legal issues affecting the asset, and will initiate a third transaction to purchase Factory 16 for no more than 19.8 million yuan [1][3]. - The third transaction involves acquiring Factory 16, which aligns with the company's strategic goals of enhancing its industrial chain and supporting its precision processing and traditional Chinese medicine technology applications [3][6]. Group 2: Rationale for Transactions - The decision to switch transaction targets is based on the need for suitable facilities to support the company's strategic layout and operational requirements, particularly for its subsidiary, Yigu Research Institute [3][6]. - The company believes that purchasing rather than leasing the factory is more cost-effective in the long term, with significant savings compared to rental costs [11][12]. Group 3: Pricing and Valuation - The pricing for the three transactions varies significantly, with the first transaction priced at 4,300 yuan per square meter, the second at 1,685.24 yuan per square meter, and the third at 2,946.32 yuan per square meter, with justifications based on construction costs and market comparisons [17][19]. - The company asserts that the pricing for the third transaction is fair and reasonable, based on asset evaluations and market conditions, and that it will adhere to the principle of "whichever is lower, the evaluation price or the provisional price" for final pricing [20][23]. Group 4: Financial Health of Related Party - As of September 30, 2025, the related party, Chuzhou Zhuyitai, has total assets of 352 million yuan and total liabilities of 214 million yuan, indicating a debt ratio of 60.70% [27][36]. - The company has provided financial guarantees and support to Chuzhou Zhuyitai, which is currently operating at a loss but has plans to improve its financial situation through strategic measures [28][31].

Group 1 - The core point of the article is that Elon Technology reported a total of 5,300 shareholders as of February 10, 2026 [2]

经核查，独立董事认为： 根据《中华人民共和国公司法》、中国证监会《上市公司独立董事管理办法》 《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律 监管指引第 1 号——规范运作》等法律法规和规范性文件以及《公司章程》等有 关规定，我们作为公司的独立董事，本着独立、客观、审慎的原则，对公司收到 的上海证券交易所问询函相关事项进行了认真核查，现就问询函问题分别发表如 下独立意见： 一、关于连续关联交易的合理性 苏州艾隆科技股份有限公司独立董事 关于上海证券交易所问询函回复的独立意见 经核查，独立董事认为： 经核查，独立董事认为： 公司 12 个月内三次向同一关联方购买厂房资产的定价依据充分，单价差异 具备合理原因，定价整体公允。三次关联交易定价均结合标的资产取得及建设成 本、周边可比资产交易单价、资产面积、配套设施完备程度等因素综合确定，其 中第一次交易单价较高系因标的资产配套设施齐全、定位贴合公司初期规划，第 二次交易单价较低系关联方给予的优惠让利，第三次交易单价结合资产实际情况 及市场公允水平协商确定，三次单价差异系不同交易标的自身条件、市场环境差 异导致，具备合理性。本次第三次交易尚未履 ...

苏州艾隆科技股份有限公司 关于收到关联交易事项的监管问询函的回复公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 苏州艾隆科技股份有限公司（以下简称"公司"或"艾隆科技"）于近日收到上海证券交 易所（以下简称"上交所"）下发的《关于苏州艾隆科技股份有限公司关联交易事项的监管工作函》 （上证科创公函[2026]0055 号）（以下简称"《监管工作函》"），公司高度重视，并组织相关部 门对《监管工作函》事项进行了分析及核查，现就《监管工作函》回复如下： 问题 1、关于连续关联交易的合理性。公告披露，公司 12 个月内连续三次拟向同一关联方购 买的厂房资产均位于安徽省滁州市泉州路 300 号，竣工日期为 2024 年 12 月 16 日。本次拟终止 第二次交易以 1,350 万元购买 1 号厂房 8,010.72 平方米并拟签署相应终止协议，同时拟开展第 三次交易以不超过 1,980 万元购买 16 号厂房 6,720.24 平方米。此外，根据 2025 年 8 月公司对 相关监管工作函的回复，公司表示公司及下属子公司不存在向滁 ...

Group 1 - The core viewpoint of the news is that Ailong Technology has seen a significant increase in its stock price, rising for nine consecutive days with a total gain of 9.74% during this period, reaching a price of 26.47 yuan per share and a market capitalization of 2.043 billion yuan [1] - Ailong Technology, established on January 20, 2006, and listed on March 29, 2021, focuses on intelligent management of medical supplies, providing comprehensive solutions through smart management devices and software platforms for healthcare institutions [1] - The company's revenue composition includes: smart emergency pharmacy products (43.34%), maintenance services (16.55%), inpatient and infusion center products (16.03%), and other categories such as intelligent warehousing (7.83%) and pharmaceutical information systems (3.84%) [1] Group 2 - According to data, the fund "Puyin Ansheng Growth Power Mixed A" holds a significant position in Ailong Technology, with 204,600 shares, representing 0.75% of the fund's net value, making it the seventh-largest holding [2] - The fund has generated a floating profit of approximately 48,070 yuan during the nine-day stock price increase, with a current floating profit of about 5,520 yuan [2] - The fund was established on March 12, 2015, with a current scale of 573 million yuan, achieving a year-to-date return of 10.51% and a one-year return of 19.61% [2]

Group 1 - The core viewpoint of the news is that Ailong Technology (688329) has shown significant growth in its revenue and net profit for the third quarter of 2025, indicating a positive trend in its financial performance [2]. - As of February 9, 2026, Ailong Technology's stock closed at 26.02 yuan, with a 1.64% increase and a trading volume of 16,700 hands, amounting to a total transaction value of 43.35 million yuan [1]. - The company reported a main business revenue of 280 million yuan for the first three quarters of 2025, representing a year-on-year increase of 25.12% [2]. Group 2 - In the third quarter of 2025, Ailong Technology achieved a single-quarter main business revenue of 149 million yuan, which is an 83.53% year-on-year increase [2]. - The net profit attributable to the parent company for the first three quarters was -959,000 yuan, but this reflects a 96.56% year-on-year improvement [2]. - The company specializes in intelligent management of medical supplies, providing comprehensive solutions through smart management devices and software platforms for medical service institutions [2].

Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Ailong Technology (688329), indicating a positive trend in revenue despite a net loss [1][2] - As of February 6, 2026, Ailong Technology's stock closed at 25.6 yuan, with a slight increase of 0.83% and a trading volume of 16,300 hands, amounting to a total transaction value of 41.79 million yuan [1] - The company reported a 25.12% year-on-year increase in main revenue for the first three quarters of 2025, totaling 280 million yuan, while the net profit attributable to shareholders was a loss of 959,000 yuan, but improved by 96.56% year-on-year [2] Group 2 - In Q3 2025, Ailong Technology achieved a quarterly main revenue of 149 million yuan, reflecting an impressive year-on-year growth of 83.53%, with a net profit of 7.43 million yuan, up 182.09% year-on-year [2] - The company specializes in intelligent management of medical supplies, providing comprehensive solutions through smart management devices and software platforms for healthcare institutions [2] - The financial metrics include a debt ratio of 42.74%, investment income of -4.25 million yuan, financial expenses of 4.69 million yuan, and a gross profit margin of 45.79% [2]